Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

IDP

Idera Pharmaceutical (IDP)

Idera Pharmaceuticals
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:IDP
DataHoraFonteTítuloCódigoCompanhia
26/11/200716:10Edgar (US Regulatory)Idera Pharmaceuticals, Inc. - Current report filing (8-K)AMEX:IDPIdera Pharmaceuticals
21/11/200720:52Edgar (US Regulatory)Idera Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4)AMEX:IDPIdera Pharmaceuticals
16/11/200719:31Edgar (US Regulatory)Idera Pharmaceuticals, Inc. - Securities Registration: Employee Benefit Plan (S-8)AMEX:IDPIdera Pharmaceuticals
13/11/200711:15Edgar (US Regulatory)Idera Pharmaceuticals, Inc. (Other) (10-Q)AMEX:IDPIdera Pharmaceuticals
09/11/200712:33Edgar (US Regulatory)Idera Pharmaceuticals, Inc. - Statement of Ownership (SC 13G)AMEX:IDPIdera Pharmaceuticals
27/09/200715:42Edgar (US Regulatory)Idera Pharmaceuticals, Inc. (Other) (4)AMEX:IDPIdera Pharmaceuticals
27/09/200715:39Edgar (US Regulatory)Idera Pharmaceuticals, Inc. (Other) (3)AMEX:IDPIdera Pharmaceuticals
27/09/200709:24Edgar (US Regulatory)Idera Pharmaceuticals, Inc. (Other) (8-K)AMEX:IDPIdera Pharmaceuticals
14/08/200709:00Business WireIdera Pharmaceuticals Announces Publication of Preclinical Data on Toll-Like Receptor 7 and 8 AgonistsAMEX:IDPIdera Pharmaceuticals
03/08/200709:00Business WireIdera Pharmaceuticals to Present at Canaccord Adams 27th Annual Global Growth ConferenceAMEX:IDPIdera Pharmaceuticals
01/08/200709:30Business WireIdera Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2007AMEX:IDPIdera Pharmaceuticals
17/07/200710:23Business WireIdera Pharmaceuticals Announces Publication of Study of Toll-Like Receptor 9 Agonist in Combination with Avastin(R) in PreclinicAMEX:IDPIdera Pharmaceuticals
17/07/200709:00Business WireIdera Pharmaceuticals Presents Preclinical Data of Toll-Like Receptor Antagonists in Rheumatoid Arthritis ModelsAMEX:IDPIdera Pharmaceuticals
21/05/200710:20Business WireIdera Pharmaceuticals Announces Chief Financial Officer to Leave Company Effective July 31, 2007AMEX:IDPIdera Pharmaceuticals
15/05/200709:00Business WireIdera Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2007AMEX:IDPIdera Pharmaceuticals
10/05/200709:00Business WireIdera Pharmaceuticals to Present at Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare ConferenceAMEX:IDPIdera Pharmaceuticals
03/05/200709:00Business WireIdera Pharmaceuticals to Present at BIO Business Forum and Participate in Toll-Like Receptor Panel at BIO 2007AMEX:IDPIdera Pharmaceuticals
18/04/200710:30Business WireIdera Pharmaceuticals Announces Presentations of Preclinical Data on New Potential Oncology Applications of its TLR9 Agonists atAMEX:IDPIdera Pharmaceuticals
05/04/200709:00Business WireIdera Pharmaceuticals to Present at CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals ConferenceAMEX:IDPIdera Pharmaceuticals
06/03/200710:00Business WireIdera Pharmaceuticals Reports Fourth Quarter and Full Year 2006 Financial ResultsAMEX:IDPIdera Pharmaceuticals
06/03/200709:30Business WireIdera Pharmaceuticals Announces Extension of Research Collaboration on Asthma and AllergyAMEX:IDPIdera Pharmaceuticals
22/01/200712:00PR Newswire (US)American Stock Exchange to Host First Annual Healthcare Conference in Boston on February 8, 2007AMEX:IDPIdera Pharmaceuticals
11/12/200611:00Business WireMerck & Co., Inc. and Idera Pharmaceuticals Sign Collaboration Agreement Incorporating Idera's Toll-like Receptor Agonists in MeAMEX:IDPIdera Pharmaceuticals
30/11/200611:15Business WireIdera Pharmaceuticals to Present at the BMO Capital Markets Focus on Healthcare ConferenceAMEX:IDPIdera Pharmaceuticals
14/11/200611:00Business WireIdera Pharmaceuticals Announces Financial Results for the Three and Nine Months Ended September 30, 2006AMEX:IDPIdera Pharmaceuticals
10/11/200613:35Business WireIdera Presents Preclinical Data on Novel Class of Toll-Like Receptor AntagonistsAMEX:IDPIdera Pharmaceuticals
01/11/200610:15Business WireIdera Pharmaceuticals to Present at Rodman & Renshaw 8th Annual Healthcare ConferenceAMEX:IDPIdera Pharmaceuticals
24/10/200609:30Business WireIdera to Draw Down $4 Million under Existing Equity VehicleAMEX:IDPIdera Pharmaceuticals
04/10/200610:25Business WireIdera Pharmaceuticals Announces Issuance of a US Patent for Method of Inducing an Immune Response through Administration of ImmuAMEX:IDPIdera Pharmaceuticals
13/09/200609:30Business WireIdera Pharmaceuticals Announces the Issuance of US Patent Claiming Compounds that Target Toll-like Receptor 9AMEX:IDPIdera Pharmaceuticals
 Apresentando as notícias mais relevantes sobre:AMEX:IDP